Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ASL 7022

Known as: ASL-7022 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
SummaryThree inotropic agents, ASL-7022, dobutamine and dopamine, were evaluated for their α-and β-adrenoceptor mediated effects… Expand
  • figure 1
  • table 1
  • figure 4
  • figure 5
  • figure 6
Is this relevant?
1989
1989
ASL-7022 is a new synthetic catecholamine with alpha and beta adrenoceptor stimulating activity having inotropic selectivity in… Expand
Is this relevant?
1989
1989
El compuesto ASL-7022 es una nueva catecolamina sintetica con actividad estimulante de los receptores alfa y beta, que ha… Expand
Is this relevant?
1985
1985
The peripheral vascular actions of i.v. administered ASL-7022 were investigated in anesthetized, open-chest dogs and in isolated… Expand
Is this relevant?
1984
1984
Three selective inotropic agents, ASL-7022, dobutamine and dopamine, were evaluated for their effects at alpha and beta… Expand
Is this relevant?
1984
1984
Three inotropic agents, ASL-7022, dobutamine and dopamine, were evaluated for their alpha- and beta-adrenoceptor mediated effects… Expand
Is this relevant?
1983
1983
ASL-7022 is a novel inotropic agent capable of increasing the force of myocardial contraction at doses which produce little… Expand
Is this relevant?
1982
1982
The effect of ganglionic blockade (GB, hexamethonium, 10 mg/kg i.v.) upon the inotropic/chronotropic actions of ASL-7022 (2-[2-(3… Expand
Is this relevant?
1982
1982
ASL-7022 (2-[3-(3,4-dihydroxy-phenyl)-1-methylethyl]-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene) was examined for… Expand
Is this relevant?